A specific photoimmunotheranostics agent to detect and eliminate skin cancer cells expressing EGFR

作者：von Felbert Verena; Bauerschlag Dirk; Maass Nicolai; Braeutigam Karen; Meinhold Heerlein Ivo; Woitok Mira; Barth Stefan; Hussain Ahmad Fawzi

来源：Journal of Cancer Research and Clinical Oncology, 2016, 142(5): 1003-1011.

DOI：10.1007/s00432-016-2122-7

• Photoimmunotheranostics
• Photodynamic therapy
• Epidermal growth factor receptor
• Targeted cancer therapy
• Malignant skin cancer

The term "theranostics" represents a new paradigm in medicine especially for cancer treatment. This term was coined by Funkhouser in 2002 and defines a reagent that combines therapeutic and diagnostic properties. It is widely believed that theranostics agents will have considerable impact on healthcare before, during, and after disease by improving cancer prognosis and management simultaneously. Current theranostics approaches still rely on passive tumor targeting strategies, which have scattergun effects and tend to damage both neoplastic and non-neoplastic cells.
Here we describe a simple, controlled, and efficient method to generate homogeneous photoimmunotheranostics reagents. This method combines molecular optical imaging, photodynamic therapy, and immunotherapy using SNAP-tag technology. SNAP-tag is a derivative of the O(6)-alkylguanine-DNA alkyltransferase (AGT) which has the ability to efficiently conjugate to O(6)-benzylguanine (BG) molecules under physiological conditions depending on its folding pattern.
The theranostics agent was able to specifically recognize various epidermal growth factor receptor (EGFR)-expressing skin cancer cell lines using flow cytometry analysis and confocal microscopy and eliminate them at EC50's of 32-55 nM.
These experiments provide a framework for using SNAP-tag technology to generate homogeneous photoimmunotheranostics reagents with unified pharmacokinetic and therapeutic profiles. Furthermore, the reagent generated in this work could be used to simultaneously monitor and suppress the growth of skin squamous carcinoma and melanoma cells expressing EGFR.

• 出版日期2016-5